Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-18-040508

Options or other derivatives

  • Chief Technology Officer acquired 12,401 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thornton Michael Milos · Chief Technology Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-28 Grant or award : show line 1 in the form Convertible Promissory Note +0 $50,000.00 $0 D
2018-06-28 Grant or award : show line 2 in the form Warrants +12,401 12,401 D
Loading xslF345X03/doc4.xml…